Itemoids

Nordisk

Ozempic maker Novo Nordisk is working on a once-monthly weight-loss drug

Quartz

qz.com › novo-nordisk-ascendis-pharma-glp-1-1851689087

Novo Nordisk (NVO), the maker of blockbuster weight-loss and diabetes drugs Wegovy and Ozempic, has entered an agreement with Denmark-based Ascendis Pharma (ASND) to leverage the latter’s advanced drug delivery technology.

Read more...